ADVA
1.12.2022 09:02:15 CET | Business Wire | Press release
ADVA (FSE: ADV) today expanded its uCPE solution with Ensemble Cloudlet. This new software is a direct response to the growing demand from enterprises for on-premises cloud solutions. With Ensemble Cloudlet, enterprises can harness edge computing to meet low-latency requirements for applications such as private 5G, AR and smart manufacturing. Removing the need for central hosting also boosts security and makes mission-critical applications more resilient. For CSPs, Ensemble Cloudlet creates an entirely new use case for uCPE. It enables them to offer customers an easily scalable edge cloud with localized control. With Ensemble Cloudlet, CSPs can effortlessly deploy and manage tens of thousands of edge clouds to host customer IT workloads, opening up a wealth of new revenue streams.
“Our Ensemble Cloudlet is a key step in the evolution of the cloud. No longer is it something hosted solely in large, centralized data centers. Now it’s easy to harness the benefits of multi-node clouds right on the customer premises. That means enterprises can utilize applications that require access to compute resources with extremely low latency. It also gives organizations with highly sensitive data the ability to keep all information in a specific area for complete data sovereignty,” said Mike Heffner, GM at Edge Cloud, ADVA. “And for CSPs, our Ensemble Cloudlet opens the door to a world of new opportunities. They already have the infrastructure in place to deliver hybrid workload clouds at the customer edge. Now we’re providing the easy scalability and secure remote management capabilities to make it work. CSPs can start with a single node and then scale up to meet customer demand.”
Ensemble Cloudlet extends traditional uCPE deployments by clustering multiple nodes together in a single cloud and delivering managed on-premises edge computing. With zero-touch provisioning, it makes deployment easy for teams without specialized expertise. Far more cost-efficient than data center cloud solutions, Ensemble Cloudlet also boosts resilience through redundant local cloud controllers and by enabling remote management. This is achieved with ADVA’s Ensemble management and orchestration suite, including Ensemble Orchestrator and Ensemble Virtualization Director, which features automation tools that reduce the need for technical resources and expert personnel.
“The launch of our Ensemble Cloudlet is big news for CSPs. The boom in uCPE deployments puts them in the perfect position to create scalable edge clouds with localized control. Now we’re giving them the tools they require to seize this new opportunity,” commented Brian Van Voorhis, director of PLM at Edge Cloud, ADVA. “For a growing number of applications, the model of a centralized data center cloud just doesn’t fit. Now CSPs can give customers access to the local cloud computing they need for use cases including VR and industrial IoT. From providing standalone resilience when network links fail to reducing backhaul for applications such as video surveillance, our Ensemble Cloudlet will be a game changer.”
Further details on Ensemble Cloudlet are available in this solution brief: https://adva.li/ensemble-cloudlet-solution-brief.
Supporting slides are also available: https://adva.li/ensemble-cloudlet-slides.
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005854/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release
Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom